
Glimidoze M 1mg/500mg Tablet SR
Marketer
Calen Biotech
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimidoze M 1mg/500mg Tablet SR
Glimidoze M 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Administer these tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including dietary adjustments, regular physical activity, and weight management as recommended by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary snacks or juice) is essential. Alcohol consumption should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood cell and liver function tests as directed by your physician, are necessary.
Uses of Glimidoze M 1mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Glimidoze M 1mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Glimidoze M 1mg/500mg Extended-Release Tablet with a meal.
Common Side effects of Glimidoze M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimidoze M 1mg/500mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Glimidoze M 1mg/500mg Extended-Release tablets with food.
How Glimidoze M 1mg/500mg Tablet SR works:
Glimidoze M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimidoze M 1mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimidoze M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Extended-release Glimidoze M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should use Glimidoze M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimidoze M 1mg/500mg SR tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Glimidoze M 1mg/500mg SR tablets cautiously. Dosage modification may be necessary for these patients. Medical advice is recommended. A low initial dose of Glimidoze M 1mg/500mg SR tablets is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe liver dysfunction.
What if you forget to take Glimidoze M 1mg/500mg Tablet SR :
Should you forget a Glimidoze M 1mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glimidoze M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
